MARIZYME, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Marizyme, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Marizyme, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $19M, a 34.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $19M +$4.88M +34.5% Dec 31, 2023 10-K 2024-05-13
Q4 2022 $14.1M +$9.05M +178% Dec 31, 2022 10-K 2024-05-13
Q4 2021 $5.09M +$1.81M +55.1% Dec 31, 2021 10-K 2023-03-24
Q4 2020 $3.28M -$2.5M -43.2% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $5.79M +$75K +1.31% Dec 31, 2019 10-K 2021-04-15
Q4 2018 $5.71M +$52K +0.92% Dec 31, 2018 10-K 2020-04-15
Q4 2017 $5.66M Dec 31, 2017 10-K 2019-03-05
Q4 2012 -$3.76M -$3.76M Dec 31, 2012 10-K/A 2014-05-08
Q4 2011 $0 Dec 31, 2011 10-K/A 2014-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.